Рецидивний папілярний рак щитоподібної залози: клініко-морфологічні особливості
DOI:
https://doi.org/10.24026/1818-1384.2(27).2009.118154Ключові слова:
thyroid, papillary carcinoma, recurrenceАнотація
In a retrospective study clinicopathological parameters predicting recurrence were determined by retrospective analysis of 21 patients with recurrent papillary thyroid carcinoma, followed for 6 to 64 months with median follow up of 22,24 months after treatment of primary papillary carcinoma of the thyroid, the authors searched for possible prognostic factors of the risk of recurrence. Because papillary thyroid carcinoma is associated with an excellent prognosis after surgical removal, large numbers of patients with extremely long term follow up are needed to identify the clinical relevance of factors prognostic for recurrence. In contrast, we recruited only a relatively small number of eligible patients with recurrent papillary thyroid carcinoma, and the median follow up period was short. The lack of association between previously determined prognostic factors and clinical recurrence in this study may have resulted from these limitations in sample size and follow up duration. Selection of proper management strategies for individual patients should be based on the results of longer term follow up studies with larger numbers of patients.Посилання
Sherman S. I. Thyroid carcinoma // Lancet. — 2003. — Vol. 361. — P 501-511.
Hodgson N.C., Button J., Solorzano C.C. Thyroid cancer: is the incidence still increasing? // Ann Surg Oncol. — 2004. — Vol. 11. — P. 1093-1097.
Davies L., Welch H.G: Increasing incidence of thyroid cancer in the United States, 1973 2002. // JAMA. — 2006. — Vol. 295. — P. 2164-2167.
Burgess J.R., Tucker P. Incidence trends for papillary thyroid carcinoma and their correlation with thyroid surgery and thyroid fine needle aspirate cytology // Thyroid. — 2006. — Vol. 16. — P. 47-53.
Mazzaferri E.L., Kloos R.T. Current approaches to primary therapy for papillary and follicular thyroid cancer // J Clin Endocrinol Metab. — 2001. — Vol. 86. — P. 1447-1462.
Eustatia Rutten C.F., Corssmit E.P., Biermasz N.R et al. Survival and death causes in differentiated thyroid carcinoma // J Clin Endocrinol Metab. — 2006 — Vol. 91. — P. 313-319.
Colonna M., Guizard A.V., Schvartz C. et al. A time trend analysis of papillary and follicular cancers as a function of tumour size: A study of data from six cancer registries in France (1983 2000) // Eur J Cancer. — 2007. — Vol. 43. — P. 891-900.
Shaha A.R. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer // Laryngoscope. — 2004. Vol. 114. — P. 393-402.
Sanders L.E., Cady B. Differentiated thyroid cancer. Reexamination of risk groups and outcome of treatment // Arch Surg. — 1998. — Vol. 124. — P. 419-425.
Kim T.Y., Hong S. J. Kim J.M. et al. Prognostic parameters for recurrence of papillary thyroid microcarcinoma // BMC Cancer. — 2008. — Vol 8. — P. 296-306.
Stojadinovic A., Shoup M., Nissan A. et al. Reccurent differentiated thyroid carcinoma: biological implication of age, method of detection, and site and extent of reccurence // Ann Surg Oncol. — 2002. — Vol. 9, N 8. — P. 789-798.
Frilling A., Gorges R., Tecklenborg K. et al. Value of preoperative diagnostic modalities in patient with recurrent thyroid carcinoma // Surgery. — 2000. — Vol. 128. — P. 945-951.
Schindler A., van Melle G., Evequoz B. et al. Prognostic factors in papillary carcinoma of the thyroid // Cancer. — 1991. — Vol. 68. — P. 324-330.
Cady B., Rossi R. An expanded view of risk group definition in differentiated thyroid carcinoma // Surgery. — 1988. — Vol. 104 — P. 947-953.
##submission.downloads##
Опубліковано
Як цитувати
Номер
Розділ
Ліцензія
Ця робота ліцензується відповідно до Creative Commons Attribution-NonCommercial 4.0 International License.